HLNE

ANALYST NOTE: HLNE (Hamilton Lane Incorporated) Date: 2026-06-13 Current Price: $82.22

1. Structural Readiness

• Conservative Entry: Not yet actionable (awaiting breakout confirmation).
• Aggressive/Pre-Breakout Entry: Not applicable for a confirmed setup; currently in the observation phase.
• Breakout Level: Not yet established (awaiting price action above the forming range).
• Current Price: $82.22.
• Extension: Not calculated (price is within the forming range, not extended above a breakout).
• ATR Context: Current ATR is 5.3% (High). This indicates elevated volatility, which is within the historical "sweet spot" (4–6%) for structural quality, suggesting the setup has sufficient momentum to move but requires careful position sizing.

2. Thesis Layer

• Thesis Classification: Tactical / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this specific setup at this date.
• Judgment Basis: Conviction must be derived strictly from the quality of the structural setup (the forming coil) and the underlying business fundamentals (AUM growth, fee generation, and strategic partnerships). Do not invent a macro narrative; judge the name on its operational execution and technical structure.

3. The Business

Hamilton Lane Incorporated operates as a global private markets investment solutions provider. As of the most recent reporting period (Q1 2026, reported May 2026), the company's business model is defined by its ability to aggregate capital and deploy it across a diverse range of private asset classes.

• Scale & Growth: As of fiscal year-end 2026, the total asset footprint stood at $1 trillion, representing a 9% year-over-year increase. Total fee-earning AUM reached $82 billion, growing 13% (or $9 billion) relative to the prior year. Discretionary AUM as of March 31, 2026, was $142 billion, up from $106 billion in March 2022 (a 7% CAGR).
• Product Mix: The firm offers a single-segment business model providing solutions across private equity, private credit, real estate, infrastructure, and growth equity.
• Evergreen Platform: The firm reported net positive inflows in aggregate for its Evergreen platform, with positive quarterly performance across all funds and no gates imposed.
• New Launches: In April 2026, the company launched the Hamilton Lane Credit Income Fund (CIF), a U.S. registered Evergreen vehicle focused on senior private credit, featuring daily subscriptions and pricing.
• Separate Accounts: Customized separate accounts comprised $98.1 billion of AUM as of December 31, 2025, where the firm holds discretionary investment authority.
• Strategic Partnerships: On November 2, 2025, the Company entered a long-term strategic partnership with The Guardian Life Insurance Company of America. Under this agreement, Hamilton Lane will oversee Guardian's existing private equity portfolio and future commitments for the next 10 years.
• Market Environment: Management noted that global buyout deal volume rose >40% in 2025, and exit value was up nearly 50%, the second-best year on record. In calendar 2026, the firm has achieved 8 exits (6 closed, 2 announced) representing over $1.2 billion in gross proceeds at a 3.6x multiple on invested capital.

4. Archetype and Conviction

• Archetype: Quality Compounder.
• *Fit:* The company demonstrates consistent AUM growth (7% CAGR), expanding fee-earning bases (13% YoY), and successful capital deployment with strong exit multiples (3.6x). The strategic partnership with Guardian provides a long-term, stable capital base, reinforcing the "compounder" profile.
• Valuation Context: The financial spine indicates a forward consensus EPS of $6.04 for FY1 and $6.10 for FY2.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical, no macro tailwind named).
• Evidence Quality: High. Multiple primary sources (earnings transcripts, 10-K/10-Q filings) confirm strong operational metrics, AUM growth, and strategic wins.
• Structural Quality: High. The ATR of 5.3% suggests a healthy, active market environment for the stock, and the "forming" coil indicates a consolidation phase that often precedes a move in quality compounders.
• Rerating Potential: Dependent on the successful scaling of the Evergreen platform and the realization of the Guardian partnership value.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the forming range (price action clearing the resistance of the coil) accompanied by volume expansion. Continued strong inflows into the Evergreen platform or further strategic partnerships would also reinforce the fundamental thesis.
• Gaps in Evidence:
• Breakout Confirmation: There is no record of a breakout firing; the setup remains in the "forming" state.
• Forward Guidance Specifics: While management expectations for the Guardian deal and fund raises are noted, specific quantitative guidance for FY2027 revenue or EPS beyond the consensus estimates is not detailed in the provided text.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: 13% YoY growth in fee-earning AUM to $82 billion; 10-year strategic partnership with Guardian Life Insurance; 3.6x multiple on 2026 exits; ATR of 5.3% indicating healthy volatility within the structural sweet spot. Key risks: Setup remains in "forming" state without confirmed breakout; reliance on continued strong private market deal volume and exit activity; potential for volatility to spike beyond the 6% threshold if market conditions deteriorate. Sizing hint: Position size should reflect the "forming" status—smaller than a confirmed breakout, but larger than a speculative entry, acknowledging the high probability of a breakout from this structure. Expected path: Management expects continued AUM growth driven by the Evergreen platform and Guardian partnership; structural implication is that once the coil breaks out, the stock may trend higher as the market re-rates the quality compounder status. Expected horizon: 3 to 6 months for the setup to resolve into a confirmed breakout or invalidation.